nodes	percent_of_prediction	percent_of_DWPC	metapath
Acetaminophen—UGT1A1—Abacavir—acquired immunodeficiency syndrome	0.0828	0.115	CbGbCtD
Acetaminophen—SLC22A6—Stavudine—acquired immunodeficiency syndrome	0.0434	0.0603	CbGbCtD
Acetaminophen—CYP2A6—Nevirapine—acquired immunodeficiency syndrome	0.0351	0.0488	CbGbCtD
Acetaminophen—SLC22A6—Didanosine—acquired immunodeficiency syndrome	0.0329	0.0457	CbGbCtD
Acetaminophen—CYP2A6—Zidovudine—acquired immunodeficiency syndrome	0.023	0.032	CbGbCtD
Acetaminophen—SLC22A6—Zidovudine—acquired immunodeficiency syndrome	0.0173	0.024	CbGbCtD
Acetaminophen—CYP2E1—Ritonavir—acquired immunodeficiency syndrome	0.0159	0.0221	CbGbCtD
Acetaminophen—CYP2C8—Amprenavir—acquired immunodeficiency syndrome	0.0156	0.0217	CbGbCtD
Acetaminophen—CYP2C8—Delavirdine—acquired immunodeficiency syndrome	0.0156	0.0217	CbGbCtD
Acetaminophen—CYP1A2—Efavirenz—acquired immunodeficiency syndrome	0.0142	0.0198	CbGbCtD
Acetaminophen—CYP1A2—Lopinavir—acquired immunodeficiency syndrome	0.0134	0.0186	CbGbCtD
Acetaminophen—CYP1A2—Nevirapine—acquired immunodeficiency syndrome	0.0134	0.0186	CbGbCtD
Acetaminophen—SLC22A6—Lamivudine—acquired immunodeficiency syndrome	0.0134	0.0186	CbGbCtD
Acetaminophen—CYP2C9—Efavirenz—acquired immunodeficiency syndrome	0.0128	0.0178	CbGbCtD
Acetaminophen—CYP1A2—Delavirdine—acquired immunodeficiency syndrome	0.0121	0.0168	CbGbCtD
Acetaminophen—CYP2C9—Lopinavir—acquired immunodeficiency syndrome	0.0121	0.0168	CbGbCtD
Acetaminophen—CYP2C9—Nevirapine—acquired immunodeficiency syndrome	0.0121	0.0168	CbGbCtD
Acetaminophen—CYP2C8—Saquinavir—acquired immunodeficiency syndrome	0.0119	0.0165	CbGbCtD
Acetaminophen—CYP2C8—Ritonavir—acquired immunodeficiency syndrome	0.0119	0.0165	CbGbCtD
Acetaminophen—CYP2D6—Efavirenz—acquired immunodeficiency syndrome	0.0117	0.0163	CbGbCtD
Acetaminophen—ABCB1—Lopinavir—acquired immunodeficiency syndrome	0.0117	0.0163	CbGbCtD
Acetaminophen—CYP2C8—Zidovudine—acquired immunodeficiency syndrome	0.0114	0.0158	CbGbCtD
Acetaminophen—CYP2D6—Lopinavir—acquired immunodeficiency syndrome	0.011	0.0153	CbGbCtD
Acetaminophen—CYP2D6—Nevirapine—acquired immunodeficiency syndrome	0.011	0.0153	CbGbCtD
Acetaminophen—CYP2C9—Amprenavir—acquired immunodeficiency syndrome	0.0109	0.0152	CbGbCtD
Acetaminophen—CYP2C9—Delavirdine—acquired immunodeficiency syndrome	0.0109	0.0152	CbGbCtD
Acetaminophen—ABCB1—Amprenavir—acquired immunodeficiency syndrome	0.0106	0.0147	CbGbCtD
Acetaminophen—CYP1A2—Nelfinavir—acquired immunodeficiency syndrome	0.0101	0.0141	CbGbCtD
Acetaminophen—CYP2D6—Amprenavir—acquired immunodeficiency syndrome	0.00998	0.0139	CbGbCtD
Acetaminophen—CYP2D6—Delavirdine—acquired immunodeficiency syndrome	0.00998	0.0139	CbGbCtD
Acetaminophen—CYP2C9—Indinavir—acquired immunodeficiency syndrome	0.00942	0.0131	CbGbCtD
Acetaminophen—CYP1A2—Ritonavir—acquired immunodeficiency syndrome	0.00918	0.0128	CbGbCtD
Acetaminophen—CYP2C9—Nelfinavir—acquired immunodeficiency syndrome	0.00914	0.0127	CbGbCtD
Acetaminophen—ABCB1—Indinavir—acquired immunodeficiency syndrome	0.00914	0.0127	CbGbCtD
Acetaminophen—ABCB1—Nelfinavir—acquired immunodeficiency syndrome	0.00887	0.0123	CbGbCtD
Acetaminophen—CYP2D6—Indinavir—acquired immunodeficiency syndrome	0.00861	0.012	CbGbCtD
Acetaminophen—CYP2D6—Nelfinavir—acquired immunodeficiency syndrome	0.00836	0.0116	CbGbCtD
Acetaminophen—CYP2C9—Ritonavir—acquired immunodeficiency syndrome	0.00827	0.0115	CbGbCtD
Acetaminophen—CYP2C9—Saquinavir—acquired immunodeficiency syndrome	0.00827	0.0115	CbGbCtD
Acetaminophen—ABCB1—Saquinavir—acquired immunodeficiency syndrome	0.00802	0.0112	CbGbCtD
Acetaminophen—ABCB1—Ritonavir—acquired immunodeficiency syndrome	0.00802	0.0112	CbGbCtD
Acetaminophen—CYP2C9—Zidovudine—acquired immunodeficiency syndrome	0.00793	0.011	CbGbCtD
Acetaminophen—ABCB1—Zidovudine—acquired immunodeficiency syndrome	0.00769	0.0107	CbGbCtD
Acetaminophen—CYP2D6—Saquinavir—acquired immunodeficiency syndrome	0.00756	0.0105	CbGbCtD
Acetaminophen—CYP2D6—Ritonavir—acquired immunodeficiency syndrome	0.00756	0.0105	CbGbCtD
Acetaminophen—CYP3A4—Efavirenz—acquired immunodeficiency syndrome	0.00746	0.0104	CbGbCtD
Acetaminophen—CYP3A4—Nevirapine—acquired immunodeficiency syndrome	0.00701	0.00975	CbGbCtD
Acetaminophen—CYP3A4—Lopinavir—acquired immunodeficiency syndrome	0.00701	0.00975	CbGbCtD
Acetaminophen—CYP3A4—Amprenavir—acquired immunodeficiency syndrome	0.00634	0.00882	CbGbCtD
Acetaminophen—CYP3A4—Delavirdine—acquired immunodeficiency syndrome	0.00634	0.00882	CbGbCtD
Acetaminophen—ABCB1—Lamivudine—acquired immunodeficiency syndrome	0.00595	0.00827	CbGbCtD
Acetaminophen—CYP3A4—Indinavir—acquired immunodeficiency syndrome	0.00548	0.00761	CbGbCtD
Acetaminophen—L-Tyrosine—TAT—acquired immunodeficiency syndrome	0.00533	1	CrCbGaD
Acetaminophen—CYP3A4—Nelfinavir—acquired immunodeficiency syndrome	0.00532	0.00739	CbGbCtD
Acetaminophen—CYP3A4—Saquinavir—acquired immunodeficiency syndrome	0.00481	0.00668	CbGbCtD
Acetaminophen—CYP3A4—Ritonavir—acquired immunodeficiency syndrome	0.00481	0.00668	CbGbCtD
Acetaminophen—CYP3A4—Zidovudine—acquired immunodeficiency syndrome	0.00461	0.00641	CbGbCtD
Acetaminophen—SULT2A1—blood plasma—acquired immunodeficiency syndrome	0.00439	0.0603	CbGeAlD
Acetaminophen—TRPV1—nerve—acquired immunodeficiency syndrome	0.00406	0.0558	CbGeAlD
Acetaminophen—UGT1A10—digestive system—acquired immunodeficiency syndrome	0.00195	0.0268	CbGeAlD
Acetaminophen—UGT1A6—digestive system—acquired immunodeficiency syndrome	0.00182	0.025	CbGeAlD
Acetaminophen—UGT1A1—blood plasma—acquired immunodeficiency syndrome	0.00175	0.024	CbGeAlD
Acetaminophen—SULT2A1—digestive system—acquired immunodeficiency syndrome	0.00169	0.0232	CbGeAlD
Acetaminophen—SULT2A1—blood—acquired immunodeficiency syndrome	0.00161	0.0221	CbGeAlD
Acetaminophen—SULT1E1—lymphoid tissue—acquired immunodeficiency syndrome	0.00158	0.0217	CbGeAlD
Acetaminophen—SULT1E1—digestive system—acquired immunodeficiency syndrome	0.00156	0.0214	CbGeAlD
Acetaminophen—SULT1E1—vagina—acquired immunodeficiency syndrome	0.00138	0.0189	CbGeAlD
Acetaminophen—SULT1A1—digestive system—acquired immunodeficiency syndrome	0.00134	0.0184	CbGeAlD
Acetaminophen—SULT2A1—nervous system—acquired immunodeficiency syndrome	0.00131	0.0179	CbGeAlD
Acetaminophen—SULT1E1—lung—acquired immunodeficiency syndrome	0.0013	0.0179	CbGeAlD
Acetaminophen—UGT2B15—digestive system—acquired immunodeficiency syndrome	0.00129	0.0178	CbGeAlD
Acetaminophen—SULT1A1—blood—acquired immunodeficiency syndrome	0.00128	0.0176	CbGeAlD
Acetaminophen—SULT2A1—central nervous system—acquired immunodeficiency syndrome	0.00126	0.0173	CbGeAlD
Acetaminophen—SULT1A1—spinal cord—acquired immunodeficiency syndrome	0.00123	0.0169	CbGeAlD
Acetaminophen—CNR1—lung—acquired immunodeficiency syndrome	0.00122	0.0167	CbGeAlD
Acetaminophen—SULT1A1—vagina—acquired immunodeficiency syndrome	0.00118	0.0163	CbGeAlD
Acetaminophen—TRPV1—digestive system—acquired immunodeficiency syndrome	0.00118	0.0162	CbGeAlD
Acetaminophen—SULT1A1—lung—acquired immunodeficiency syndrome	0.00112	0.0154	CbGeAlD
Acetaminophen—TRPV1—spinal cord—acquired immunodeficiency syndrome	0.00108	0.0149	CbGeAlD
Acetaminophen—SULT1A1—nervous system—acquired immunodeficiency syndrome	0.00104	0.0143	CbGeAlD
Acetaminophen—SULT1A1—central nervous system—acquired immunodeficiency syndrome	0.000999	0.0137	CbGeAlD
Acetaminophen—SULT2A1—brain—acquired immunodeficiency syndrome	0.000998	0.0137	CbGeAlD
Acetaminophen—UGT1A9—digestive system—acquired immunodeficiency syndrome	0.000981	0.0135	CbGeAlD
Acetaminophen—SULT2A1—lymph node—acquired immunodeficiency syndrome	0.000964	0.0133	CbGeAlD
Acetaminophen—TRPV1—nervous system—acquired immunodeficiency syndrome	0.000913	0.0125	CbGeAlD
Acetaminophen—SULT1E1—lymph node—acquired immunodeficiency syndrome	0.00089	0.0122	CbGeAlD
Acetaminophen—TRPV1—central nervous system—acquired immunodeficiency syndrome	0.000879	0.0121	CbGeAlD
Acetaminophen—CNR1—brain—acquired immunodeficiency syndrome	0.000861	0.0118	CbGeAlD
Acetaminophen—CNR1—lymph node—acquired immunodeficiency syndrome	0.000832	0.0114	CbGeAlD
Acetaminophen—CYP2C8—blood plasma—acquired immunodeficiency syndrome	0.000827	0.0114	CbGeAlD
Acetaminophen—SULT1A1—brain—acquired immunodeficiency syndrome	0.000793	0.0109	CbGeAlD
Acetaminophen—CYP1A2—blood plasma—acquired immunodeficiency syndrome	0.000774	0.0106	CbGeAlD
Acetaminophen—SULT1A1—lymph node—acquired immunodeficiency syndrome	0.000766	0.0105	CbGeAlD
Acetaminophen—PTGS1—endothelium—acquired immunodeficiency syndrome	0.000755	0.0104	CbGeAlD
Acetaminophen—CYP2C9—blood plasma—acquired immunodeficiency syndrome	0.000735	0.0101	CbGeAlD
Acetaminophen—PTGS2—endothelium—acquired immunodeficiency syndrome	0.000722	0.00992	CbGeAlD
Acetaminophen—TRPV1—brain—acquired immunodeficiency syndrome	0.000698	0.00959	CbGeAlD
Acetaminophen—CYP2E1—blood plasma—acquired immunodeficiency syndrome	0.000696	0.00957	CbGeAlD
Acetaminophen—UGT1A1—digestive system—acquired immunodeficiency syndrome	0.000672	0.00924	CbGeAlD
Acetaminophen—PTGS1—blood plasma—acquired immunodeficiency syndrome	0.000671	0.00921	CbGeAlD
Acetaminophen—PTGS2—blood plasma—acquired immunodeficiency syndrome	0.000641	0.00881	CbGeAlD
Acetaminophen—UGT1A1—blood—acquired immunodeficiency syndrome	0.00064	0.0088	CbGeAlD
Acetaminophen—CYP3A4—blood plasma—acquired immunodeficiency syndrome	0.00056	0.0077	CbGeAlD
Acetaminophen—CYP2D6—blood plasma—acquired immunodeficiency syndrome	0.000551	0.00757	CbGeAlD
Acetaminophen—CYP2A6—vagina—acquired immunodeficiency syndrome	0.0005	0.00687	CbGeAlD
Acetaminophen—CYP2A6—lung—acquired immunodeficiency syndrome	0.000473	0.0065	CbGeAlD
Acetaminophen—SLC22A6—brain—acquired immunodeficiency syndrome	0.000429	0.0059	CbGeAlD
Acetaminophen—ABCB1—blood plasma—acquired immunodeficiency syndrome	0.000396	0.00545	CbGeAlD
Acetaminophen—CYP1A1—skin of body—acquired immunodeficiency syndrome	0.000367	0.00504	CbGeAlD
Acetaminophen—CYP2A6—brain—acquired immunodeficiency syndrome	0.000335	0.0046	CbGeAlD
Acetaminophen—PTGS1—skin of body—acquired immunodeficiency syndrome	0.000322	0.00443	CbGeAlD
Acetaminophen—PTGS2—skin of body—acquired immunodeficiency syndrome	0.000308	0.00423	CbGeAlD
Acetaminophen—CYP2C8—blood—acquired immunodeficiency syndrome	0.000303	0.00416	CbGeAlD
Acetaminophen—CYP1A2—digestive system—acquired immunodeficiency syndrome	0.000298	0.00409	CbGeAlD
Acetaminophen—CYP1A1—digestive system—acquired immunodeficiency syndrome	0.000294	0.00403	CbGeAlD
Acetaminophen—CYP1A2—blood—acquired immunodeficiency syndrome	0.000283	0.0039	CbGeAlD
Acetaminophen—CYP2C9—digestive system—acquired immunodeficiency syndrome	0.000282	0.00388	CbGeAlD
Acetaminophen—CYP2C8—vagina—acquired immunodeficiency syndrome	0.000281	0.00386	CbGeAlD
Acetaminophen—CYP1A1—blood—acquired immunodeficiency syndrome	0.00028	0.00384	CbGeAlD
Acetaminophen—CYP2E1—lymphoid tissue—acquired immunodeficiency syndrome	0.000271	0.00372	CbGeAlD
Acetaminophen—CYP2C9—blood—acquired immunodeficiency syndrome	0.000269	0.0037	CbGeAlD
Acetaminophen—CYP2E1—digestive system—acquired immunodeficiency syndrome	0.000268	0.00368	CbGeAlD
Acetaminophen—CYP1A1—vagina—acquired immunodeficiency syndrome	0.000259	0.00356	CbGeAlD
Acetaminophen—PTGS1—digestive system—acquired immunodeficiency syndrome	0.000258	0.00354	CbGeAlD
Acetaminophen—CYP2E1—blood—acquired immunodeficiency syndrome	0.000255	0.0035	CbGeAlD
Acetaminophen—PTGS2—lymphoid tissue—acquired immunodeficiency syndrome	0.00025	0.00343	CbGeAlD
Acetaminophen—CYP1A2—lung—acquired immunodeficiency syndrome	0.000249	0.00341	CbGeAlD
Acetaminophen—PTGS2—digestive system—acquired immunodeficiency syndrome	0.000246	0.00339	CbGeAlD
Acetaminophen—CYP2E1—spinal cord—acquired immunodeficiency syndrome	0.000246	0.00338	CbGeAlD
Acetaminophen—PTGS1—blood—acquired immunodeficiency syndrome	0.000246	0.00338	CbGeAlD
Acetaminophen—CYP1A1—lung—acquired immunodeficiency syndrome	0.000245	0.00337	CbGeAlD
Acetaminophen—PTGS1—spinal cord—acquired immunodeficiency syndrome	0.000237	0.00325	CbGeAlD
Acetaminophen—PTGS2—blood—acquired immunodeficiency syndrome	0.000235	0.00323	CbGeAlD
Acetaminophen—PTGS1—vagina—acquired immunodeficiency syndrome	0.000228	0.00313	CbGeAlD
Acetaminophen—PTGS2—bone marrow—acquired immunodeficiency syndrome	0.000227	0.00312	CbGeAlD
Acetaminophen—CYP1A1—nervous system—acquired immunodeficiency syndrome	0.000227	0.00312	CbGeAlD
Acetaminophen—PTGS2—spinal cord—acquired immunodeficiency syndrome	0.000226	0.00311	CbGeAlD
Acetaminophen—CYP2E1—lung—acquired immunodeficiency syndrome	0.000224	0.00307	CbGeAlD
Acetaminophen—CYP1A1—central nervous system—acquired immunodeficiency syndrome	0.000219	0.003	CbGeAlD
Acetaminophen—PTGS2—vagina—acquired immunodeficiency syndrome	0.000218	0.00299	CbGeAlD
Acetaminophen—ABCB1—retina—acquired immunodeficiency syndrome	0.000217	0.00298	CbGeAlD
Acetaminophen—CYP3A4—digestive system—acquired immunodeficiency syndrome	0.000215	0.00296	CbGeAlD
Acetaminophen—PTGS1—lung—acquired immunodeficiency syndrome	0.000215	0.00296	CbGeAlD
Acetaminophen—CYP2D6—digestive system—acquired immunodeficiency syndrome	0.000212	0.00291	CbGeAlD
Acetaminophen—CYP2E1—nervous system—acquired immunodeficiency syndrome	0.000207	0.00284	CbGeAlD
Acetaminophen—PTGS2—lung—acquired immunodeficiency syndrome	0.000206	0.00283	CbGeAlD
Acetaminophen—CYP3A4—blood—acquired immunodeficiency syndrome	0.000205	0.00282	CbGeAlD
Acetaminophen—CYP2D6—blood—acquired immunodeficiency syndrome	0.000202	0.00277	CbGeAlD
Acetaminophen—PTGS1—nervous system—acquired immunodeficiency syndrome	0.000199	0.00274	CbGeAlD
Acetaminophen—CYP2E1—central nervous system—acquired immunodeficiency syndrome	0.000199	0.00274	CbGeAlD
Acetaminophen—PTGS1—central nervous system—acquired immunodeficiency syndrome	0.000192	0.00264	CbGeAlD
Acetaminophen—PTGS2—nervous system—acquired immunodeficiency syndrome	0.000191	0.00262	CbGeAlD
Acetaminophen—CYP2C8—brain—acquired immunodeficiency syndrome	0.000188	0.00258	CbGeAlD
Acetaminophen—PTGS2—central nervous system—acquired immunodeficiency syndrome	0.000184	0.00252	CbGeAlD
Acetaminophen—CYP1A1—brain—acquired immunodeficiency syndrome	0.000174	0.00238	CbGeAlD
Acetaminophen—CYP1A1—lymph node—acquired immunodeficiency syndrome	0.000168	0.0023	CbGeAlD
Acetaminophen—CYP3A4—nervous system—acquired immunodeficiency syndrome	0.000167	0.00229	CbGeAlD
Acetaminophen—CYP2D6—nervous system—acquired immunodeficiency syndrome	0.000164	0.00225	CbGeAlD
Acetaminophen—CYP3A4—central nervous system—acquired immunodeficiency syndrome	0.00016	0.0022	CbGeAlD
Acetaminophen—CYP2E1—brain—acquired immunodeficiency syndrome	0.000158	0.00217	CbGeAlD
Acetaminophen—CYP2D6—central nervous system—acquired immunodeficiency syndrome	0.000158	0.00217	CbGeAlD
Acetaminophen—ABCB1—lymphoid tissue—acquired immunodeficiency syndrome	0.000154	0.00212	CbGeAlD
Acetaminophen—ABCB1—digestive system—acquired immunodeficiency syndrome	0.000152	0.00209	CbGeAlD
Acetaminophen—PTGS1—brain—acquired immunodeficiency syndrome	0.000152	0.00209	CbGeAlD
Acetaminophen—PTGS1—lymph node—acquired immunodeficiency syndrome	0.000147	0.00202	CbGeAlD
Acetaminophen—PTGS2—brain—acquired immunodeficiency syndrome	0.000146	0.002	CbGeAlD
Acetaminophen—ABCB1—blood—acquired immunodeficiency syndrome	0.000145	0.002	CbGeAlD
Acetaminophen—Asthenia—Nelfinavir—acquired immunodeficiency syndrome	0.000145	0.000717	CcSEcCtD
Acetaminophen—Shock—Delavirdine—acquired immunodeficiency syndrome	0.000145	0.000716	CcSEcCtD
Acetaminophen—Malaise—Saquinavir—acquired immunodeficiency syndrome	0.000145	0.000716	CcSEcCtD
Acetaminophen—Somnolence—Indinavir—acquired immunodeficiency syndrome	0.000145	0.000716	CcSEcCtD
Acetaminophen—Asthenia—Stavudine—acquired immunodeficiency syndrome	0.000144	0.000714	CcSEcCtD
Acetaminophen—Convulsion—Ritonavir—acquired immunodeficiency syndrome	0.000144	0.000714	CcSEcCtD
Acetaminophen—Feeling abnormal—Zidovudine—acquired immunodeficiency syndrome	0.000144	0.000713	CcSEcCtD
Acetaminophen—Thrombocytopenia—Delavirdine—acquired immunodeficiency syndrome	0.000144	0.000712	CcSEcCtD
Acetaminophen—Hypertension—Ritonavir—acquired immunodeficiency syndrome	0.000144	0.000712	CcSEcCtD
Acetaminophen—Leukopenia—Saquinavir—acquired immunodeficiency syndrome	0.000144	0.00071	CcSEcCtD
Acetaminophen—Tachycardia—Delavirdine—acquired immunodeficiency syndrome	0.000144	0.00071	CcSEcCtD
Acetaminophen—Tremor—Lamivudine—acquired immunodeficiency syndrome	0.000143	0.000709	CcSEcCtD
Acetaminophen—Dyspepsia—Indinavir—acquired immunodeficiency syndrome	0.000143	0.000708	CcSEcCtD
Acetaminophen—Gastrointestinal pain—Zidovudine—acquired immunodeficiency syndrome	0.000143	0.000708	CcSEcCtD
Acetaminophen—Skin disorder—Delavirdine—acquired immunodeficiency syndrome	0.000143	0.000707	CcSEcCtD
Acetaminophen—Pruritus—Nelfinavir—acquired immunodeficiency syndrome	0.000143	0.000707	CcSEcCtD
Acetaminophen—Diarrhoea—Nevirapine—acquired immunodeficiency syndrome	0.000143	0.000706	CcSEcCtD
Acetaminophen—Pruritus—Stavudine—acquired immunodeficiency syndrome	0.000142	0.000704	CcSEcCtD
Acetaminophen—Asthenia—Abacavir—acquired immunodeficiency syndrome	0.000142	0.000704	CcSEcCtD
Acetaminophen—Hyperhidrosis—Delavirdine—acquired immunodeficiency syndrome	0.000142	0.000703	CcSEcCtD
Acetaminophen—Ill-defined disorder—Lamivudine—acquired immunodeficiency syndrome	0.000142	0.000702	CcSEcCtD
Acetaminophen—Chest pain—Ritonavir—acquired immunodeficiency syndrome	0.000142	0.000702	CcSEcCtD
Acetaminophen—Decreased appetite—Indinavir—acquired immunodeficiency syndrome	0.000142	0.0007	CcSEcCtD
Acetaminophen—Anaemia—Lamivudine—acquired immunodeficiency syndrome	0.000142	0.0007	CcSEcCtD
Acetaminophen—Anxiety—Ritonavir—acquired immunodeficiency syndrome	0.000141	0.000699	CcSEcCtD
Acetaminophen—Unspecified disorder of skin and subcutaneous tissue—Ritonavir—acquired immunodeficiency syndrome	0.000141	0.000697	CcSEcCtD
Acetaminophen—PTGS2—lymph node—acquired immunodeficiency syndrome	0.000141	0.00193	CbGeAlD
Acetaminophen—Gastrointestinal disorder—Indinavir—acquired immunodeficiency syndrome	0.000141	0.000695	CcSEcCtD
Acetaminophen—ABCB1—bone marrow—acquired immunodeficiency syndrome	0.000141	0.00193	CbGeAlD
Acetaminophen—Pruritus—Abacavir—acquired immunodeficiency syndrome	0.00014	0.000694	CcSEcCtD
Acetaminophen—Fatigue—Indinavir—acquired immunodeficiency syndrome	0.00014	0.000694	CcSEcCtD
Acetaminophen—Anorexia—Delavirdine—acquired immunodeficiency syndrome	0.00014	0.000694	CcSEcCtD
Acetaminophen—Discomfort—Ritonavir—acquired immunodeficiency syndrome	0.00014	0.000693	CcSEcCtD
Acetaminophen—Cough—Saquinavir—acquired immunodeficiency syndrome	0.00014	0.000692	CcSEcCtD
Acetaminophen—ABCB1—spinal cord—acquired immunodeficiency syndrome	0.00014	0.00192	CbGeAlD
Acetaminophen—Angioedema—Lamivudine—acquired immunodeficiency syndrome	0.00014	0.000692	CcSEcCtD
Acetaminophen—Constipation—Indinavir—acquired immunodeficiency syndrome	0.000139	0.000688	CcSEcCtD
Acetaminophen—Insomnia—Efavirenz—acquired immunodeficiency syndrome	0.000139	0.000688	CcSEcCtD
Acetaminophen—Urticaria—Zidovudine—acquired immunodeficiency syndrome	0.000139	0.000688	CcSEcCtD
Acetaminophen—Convulsion—Saquinavir—acquired immunodeficiency syndrome	0.000139	0.000688	CcSEcCtD
Acetaminophen—Dry mouth—Ritonavir—acquired immunodeficiency syndrome	0.000139	0.000686	CcSEcCtD
Acetaminophen—Hypertension—Saquinavir—acquired immunodeficiency syndrome	0.000139	0.000685	CcSEcCtD
Acetaminophen—Body temperature increased—Zidovudine—acquired immunodeficiency syndrome	0.000138	0.000684	CcSEcCtD
Acetaminophen—Abdominal pain—Zidovudine—acquired immunodeficiency syndrome	0.000138	0.000684	CcSEcCtD
Acetaminophen—Diarrhoea—Nelfinavir—acquired immunodeficiency syndrome	0.000138	0.000683	CcSEcCtD
Acetaminophen—Malaise—Lamivudine—acquired immunodeficiency syndrome	0.000138	0.000683	CcSEcCtD
Acetaminophen—Diarrhoea—Stavudine—acquired immunodeficiency syndrome	0.000138	0.000681	CcSEcCtD
Acetaminophen—Nausea—Didanosine—acquired immunodeficiency syndrome	0.000138	0.000681	CcSEcCtD
Acetaminophen—Hypotension—Delavirdine—acquired immunodeficiency syndrome	0.000138	0.00068	CcSEcCtD
Acetaminophen—Confusional state—Ritonavir—acquired immunodeficiency syndrome	0.000137	0.000678	CcSEcCtD
Acetaminophen—Dyspnoea—Efavirenz—acquired immunodeficiency syndrome	0.000137	0.000678	CcSEcCtD
Acetaminophen—Leukopenia—Lamivudine—acquired immunodeficiency syndrome	0.000137	0.000678	CcSEcCtD
Acetaminophen—Somnolence—Efavirenz—acquired immunodeficiency syndrome	0.000137	0.000676	CcSEcCtD
Acetaminophen—Chest pain—Saquinavir—acquired immunodeficiency syndrome	0.000137	0.000676	CcSEcCtD
Acetaminophen—Anxiety—Saquinavir—acquired immunodeficiency syndrome	0.000136	0.000673	CcSEcCtD
Acetaminophen—Oedema—Ritonavir—acquired immunodeficiency syndrome	0.000136	0.000673	CcSEcCtD
Acetaminophen—Diarrhoea—Abacavir—acquired immunodeficiency syndrome	0.000136	0.000671	CcSEcCtD
Acetaminophen—Unspecified disorder of skin and subcutaneous tissue—Saquinavir—acquired immunodeficiency syndrome	0.000136	0.000671	CcSEcCtD
Acetaminophen—Dyspepsia—Efavirenz—acquired immunodeficiency syndrome	0.000135	0.000669	CcSEcCtD
Acetaminophen—Discomfort—Saquinavir—acquired immunodeficiency syndrome	0.000135	0.000667	CcSEcCtD
Acetaminophen—ABCB1—vagina—acquired immunodeficiency syndrome	0.000135	0.00185	CbGeAlD
Acetaminophen—Feeling abnormal—Indinavir—acquired immunodeficiency syndrome	0.000134	0.000663	CcSEcCtD
Acetaminophen—Shock—Ritonavir—acquired immunodeficiency syndrome	0.000134	0.000662	CcSEcCtD
Acetaminophen—Decreased appetite—Efavirenz—acquired immunodeficiency syndrome	0.000134	0.000661	CcSEcCtD
Acetaminophen—Dry mouth—Saquinavir—acquired immunodeficiency syndrome	0.000134	0.000661	CcSEcCtD
Acetaminophen—Cough—Lamivudine—acquired immunodeficiency syndrome	0.000134	0.000661	CcSEcCtD
Acetaminophen—Dizziness—Nelfinavir—acquired immunodeficiency syndrome	0.000134	0.00066	CcSEcCtD
Acetaminophen—Nervous system disorder—Ritonavir—acquired immunodeficiency syndrome	0.000133	0.00066	CcSEcCtD
Acetaminophen—Thrombocytopenia—Ritonavir—acquired immunodeficiency syndrome	0.000133	0.000659	CcSEcCtD
Acetaminophen—Dizziness—Stavudine—acquired immunodeficiency syndrome	0.000133	0.000658	CcSEcCtD
Acetaminophen—Gastrointestinal pain—Indinavir—acquired immunodeficiency syndrome	0.000133	0.000658	CcSEcCtD
Acetaminophen—Insomnia—Delavirdine—acquired immunodeficiency syndrome	0.000133	0.000658	CcSEcCtD
Acetaminophen—Tachycardia—Ritonavir—acquired immunodeficiency syndrome	0.000133	0.000657	CcSEcCtD
Acetaminophen—Gastrointestinal disorder—Efavirenz—acquired immunodeficiency syndrome	0.000133	0.000657	CcSEcCtD
Acetaminophen—Convulsion—Lamivudine—acquired immunodeficiency syndrome	0.000133	0.000656	CcSEcCtD
Acetaminophen—Vomiting—Nevirapine—acquired immunodeficiency syndrome	0.000133	0.000656	CcSEcCtD
Acetaminophen—Fatigue—Efavirenz—acquired immunodeficiency syndrome	0.000133	0.000656	CcSEcCtD
Acetaminophen—Skin disorder—Ritonavir—acquired immunodeficiency syndrome	0.000132	0.000654	CcSEcCtD
Acetaminophen—Confusional state—Saquinavir—acquired immunodeficiency syndrome	0.000132	0.000653	CcSEcCtD
Acetaminophen—Hyperhidrosis—Ritonavir—acquired immunodeficiency syndrome	0.000132	0.00065	CcSEcCtD
Acetaminophen—Constipation—Efavirenz—acquired immunodeficiency syndrome	0.000132	0.00065	CcSEcCtD
Acetaminophen—Rash—Nevirapine—acquired immunodeficiency syndrome	0.000132	0.00065	CcSEcCtD
Acetaminophen—Dermatitis—Nevirapine—acquired immunodeficiency syndrome	0.000131	0.00065	CcSEcCtD
Acetaminophen—Dyspnoea—Delavirdine—acquired immunodeficiency syndrome	0.000131	0.000649	CcSEcCtD
Acetaminophen—Dizziness—Abacavir—acquired immunodeficiency syndrome	0.000131	0.000649	CcSEcCtD
Acetaminophen—Oedema—Saquinavir—acquired immunodeficiency syndrome	0.000131	0.000648	CcSEcCtD
Acetaminophen—Somnolence—Delavirdine—acquired immunodeficiency syndrome	0.000131	0.000647	CcSEcCtD
Acetaminophen—Headache—Nevirapine—acquired immunodeficiency syndrome	0.000131	0.000646	CcSEcCtD
Acetaminophen—Chest pain—Lamivudine—acquired immunodeficiency syndrome	0.00013	0.000644	CcSEcCtD
Acetaminophen—Anxiety—Lamivudine—acquired immunodeficiency syndrome	0.00013	0.000642	CcSEcCtD
Acetaminophen—Anorexia—Ritonavir—acquired immunodeficiency syndrome	0.00013	0.000641	CcSEcCtD
Acetaminophen—Dyspepsia—Delavirdine—acquired immunodeficiency syndrome	0.00013	0.00064	CcSEcCtD
Acetaminophen—Unspecified disorder of skin and subcutaneous tissue—Lamivudine—acquired immunodeficiency syndrome	0.000129	0.00064	CcSEcCtD
Acetaminophen—Urticaria—Indinavir—acquired immunodeficiency syndrome	0.000129	0.000639	CcSEcCtD
Acetaminophen—Shock—Saquinavir—acquired immunodeficiency syndrome	0.000129	0.000637	CcSEcCtD
Acetaminophen—Discomfort—Lamivudine—acquired immunodeficiency syndrome	0.000129	0.000637	CcSEcCtD
Acetaminophen—Abdominal pain—Indinavir—acquired immunodeficiency syndrome	0.000129	0.000636	CcSEcCtD
Acetaminophen—Body temperature increased—Indinavir—acquired immunodeficiency syndrome	0.000129	0.000636	CcSEcCtD
Acetaminophen—Nervous system disorder—Saquinavir—acquired immunodeficiency syndrome	0.000128	0.000635	CcSEcCtD
Acetaminophen—Vomiting—Nelfinavir—acquired immunodeficiency syndrome	0.000128	0.000635	CcSEcCtD
Acetaminophen—Thrombocytopenia—Saquinavir—acquired immunodeficiency syndrome	0.000128	0.000634	CcSEcCtD
Acetaminophen—Vomiting—Stavudine—acquired immunodeficiency syndrome	0.000128	0.000633	CcSEcCtD
Acetaminophen—Decreased appetite—Delavirdine—acquired immunodeficiency syndrome	0.000128	0.000633	CcSEcCtD
Acetaminophen—Dry mouth—Lamivudine—acquired immunodeficiency syndrome	0.000127	0.00063	CcSEcCtD
Acetaminophen—Rash—Nelfinavir—acquired immunodeficiency syndrome	0.000127	0.00063	CcSEcCtD
Acetaminophen—ABCB1—lung—acquired immunodeficiency syndrome	0.000127	0.00175	CbGeAlD
Acetaminophen—Dermatitis—Nelfinavir—acquired immunodeficiency syndrome	0.000127	0.000629	CcSEcCtD
Acetaminophen—Skin disorder—Saquinavir—acquired immunodeficiency syndrome	0.000127	0.000629	CcSEcCtD
Acetaminophen—Hypotension—Ritonavir—acquired immunodeficiency syndrome	0.000127	0.000629	CcSEcCtD
Acetaminophen—Gastrointestinal disorder—Delavirdine—acquired immunodeficiency syndrome	0.000127	0.000628	CcSEcCtD
Acetaminophen—Rash—Stavudine—acquired immunodeficiency syndrome	0.000127	0.000628	CcSEcCtD
Acetaminophen—Fatigue—Delavirdine—acquired immunodeficiency syndrome	0.000127	0.000627	CcSEcCtD
Acetaminophen—Dermatitis—Stavudine—acquired immunodeficiency syndrome	0.000127	0.000627	CcSEcCtD
Acetaminophen—Feeling abnormal—Efavirenz—acquired immunodeficiency syndrome	0.000127	0.000627	CcSEcCtD
Acetaminophen—Hyperhidrosis—Saquinavir—acquired immunodeficiency syndrome	0.000127	0.000626	CcSEcCtD
Acetaminophen—Headache—Nelfinavir—acquired immunodeficiency syndrome	0.000127	0.000626	CcSEcCtD
Acetaminophen—Headache—Stavudine—acquired immunodeficiency syndrome	0.000126	0.000624	CcSEcCtD
Acetaminophen—Vomiting—Abacavir—acquired immunodeficiency syndrome	0.000126	0.000624	CcSEcCtD
Acetaminophen—Confusional state—Lamivudine—acquired immunodeficiency syndrome	0.000126	0.000623	CcSEcCtD
Acetaminophen—Constipation—Delavirdine—acquired immunodeficiency syndrome	0.000126	0.000622	CcSEcCtD
Acetaminophen—Gastrointestinal pain—Efavirenz—acquired immunodeficiency syndrome	0.000126	0.000622	CcSEcCtD
Acetaminophen—Asthenia—Zidovudine—acquired immunodeficiency syndrome	0.000126	0.000621	CcSEcCtD
Acetaminophen—CYP2D6—brain—acquired immunodeficiency syndrome	0.000125	0.00172	CbGeAlD
Acetaminophen—Rash—Abacavir—acquired immunodeficiency syndrome	0.000125	0.000618	CcSEcCtD
Acetaminophen—Dermatitis—Abacavir—acquired immunodeficiency syndrome	0.000125	0.000618	CcSEcCtD
Acetaminophen—Anaphylactic shock—Lamivudine—acquired immunodeficiency syndrome	0.000125	0.000618	CcSEcCtD
Acetaminophen—Oedema—Lamivudine—acquired immunodeficiency syndrome	0.000125	0.000618	CcSEcCtD
Acetaminophen—Anorexia—Saquinavir—acquired immunodeficiency syndrome	0.000125	0.000617	CcSEcCtD
Acetaminophen—Headache—Abacavir—acquired immunodeficiency syndrome	0.000124	0.000615	CcSEcCtD
Acetaminophen—Nausea—Nevirapine—acquired immunodeficiency syndrome	0.000124	0.000613	CcSEcCtD
Acetaminophen—Pruritus—Zidovudine—acquired immunodeficiency syndrome	0.000124	0.000612	CcSEcCtD
Acetaminophen—Insomnia—Ritonavir—acquired immunodeficiency syndrome	0.000123	0.000609	CcSEcCtD
Acetaminophen—Shock—Lamivudine—acquired immunodeficiency syndrome	0.000123	0.000608	CcSEcCtD
Acetaminophen—Nervous system disorder—Lamivudine—acquired immunodeficiency syndrome	0.000123	0.000606	CcSEcCtD
Acetaminophen—Hypotension—Saquinavir—acquired immunodeficiency syndrome	0.000122	0.000605	CcSEcCtD
Acetaminophen—Thrombocytopenia—Lamivudine—acquired immunodeficiency syndrome	0.000122	0.000605	CcSEcCtD
Acetaminophen—Urticaria—Efavirenz—acquired immunodeficiency syndrome	0.000122	0.000604	CcSEcCtD
Acetaminophen—Abdominal pain—Efavirenz—acquired immunodeficiency syndrome	0.000122	0.000601	CcSEcCtD
Acetaminophen—Body temperature increased—Efavirenz—acquired immunodeficiency syndrome	0.000122	0.000601	CcSEcCtD
Acetaminophen—Skin disorder—Lamivudine—acquired immunodeficiency syndrome	0.000121	0.0006	CcSEcCtD
Acetaminophen—Dyspnoea—Ritonavir—acquired immunodeficiency syndrome	0.000121	0.0006	CcSEcCtD
Acetaminophen—Feeling abnormal—Delavirdine—acquired immunodeficiency syndrome	0.000121	0.0006	CcSEcCtD
Acetaminophen—Somnolence—Ritonavir—acquired immunodeficiency syndrome	0.000121	0.000598	CcSEcCtD
Acetaminophen—Hyperhidrosis—Lamivudine—acquired immunodeficiency syndrome	0.000121	0.000597	CcSEcCtD
Acetaminophen—Gastrointestinal pain—Delavirdine—acquired immunodeficiency syndrome	0.00012	0.000595	CcSEcCtD
Acetaminophen—Nausea—Nelfinavir—acquired immunodeficiency syndrome	0.00012	0.000593	CcSEcCtD
Acetaminophen—Hypersensitivity—Indinavir—acquired immunodeficiency syndrome	0.00012	0.000593	CcSEcCtD
Acetaminophen—Dyspepsia—Ritonavir—acquired immunodeficiency syndrome	0.00012	0.000592	CcSEcCtD
Acetaminophen—Diarrhoea—Zidovudine—acquired immunodeficiency syndrome	0.00012	0.000592	CcSEcCtD
Acetaminophen—Nausea—Stavudine—acquired immunodeficiency syndrome	0.00012	0.000591	CcSEcCtD
Acetaminophen—Anorexia—Lamivudine—acquired immunodeficiency syndrome	0.000119	0.000589	CcSEcCtD
Acetaminophen—Insomnia—Saquinavir—acquired immunodeficiency syndrome	0.000118	0.000586	CcSEcCtD
Acetaminophen—Decreased appetite—Ritonavir—acquired immunodeficiency syndrome	0.000118	0.000585	CcSEcCtD
Acetaminophen—ABCB1—nervous system—acquired immunodeficiency syndrome	0.000118	0.00162	CbGeAlD
Acetaminophen—Nausea—Abacavir—acquired immunodeficiency syndrome	0.000118	0.000583	CcSEcCtD
Acetaminophen—Gastrointestinal disorder—Ritonavir—acquired immunodeficiency syndrome	0.000117	0.000581	CcSEcCtD
Acetaminophen—Fatigue—Ritonavir—acquired immunodeficiency syndrome	0.000117	0.00058	CcSEcCtD
Acetaminophen—Urticaria—Delavirdine—acquired immunodeficiency syndrome	0.000117	0.000578	CcSEcCtD
Acetaminophen—Asthenia—Indinavir—acquired immunodeficiency syndrome	0.000117	0.000577	CcSEcCtD
Acetaminophen—Dyspnoea—Saquinavir—acquired immunodeficiency syndrome	0.000117	0.000577	CcSEcCtD
Acetaminophen—Hypotension—Lamivudine—acquired immunodeficiency syndrome	0.000117	0.000577	CcSEcCtD
Acetaminophen—Somnolence—Saquinavir—acquired immunodeficiency syndrome	0.000116	0.000576	CcSEcCtD
Acetaminophen—Constipation—Ritonavir—acquired immunodeficiency syndrome	0.000116	0.000575	CcSEcCtD
Acetaminophen—Abdominal pain—Delavirdine—acquired immunodeficiency syndrome	0.000116	0.000575	CcSEcCtD
Acetaminophen—Body temperature increased—Delavirdine—acquired immunodeficiency syndrome	0.000116	0.000575	CcSEcCtD
Acetaminophen—Dizziness—Zidovudine—acquired immunodeficiency syndrome	0.000116	0.000572	CcSEcCtD
Acetaminophen—Dyspepsia—Saquinavir—acquired immunodeficiency syndrome	0.000115	0.00057	CcSEcCtD
Acetaminophen—Pruritus—Indinavir—acquired immunodeficiency syndrome	0.000115	0.000569	CcSEcCtD
Acetaminophen—Decreased appetite—Saquinavir—acquired immunodeficiency syndrome	0.000114	0.000563	CcSEcCtD
Acetaminophen—ABCB1—central nervous system—acquired immunodeficiency syndrome	0.000114	0.00156	CbGeAlD
Acetaminophen—Hypersensitivity—Efavirenz—acquired immunodeficiency syndrome	0.000113	0.00056	CcSEcCtD
Acetaminophen—Gastrointestinal disorder—Saquinavir—acquired immunodeficiency syndrome	0.000113	0.000559	CcSEcCtD
Acetaminophen—Insomnia—Lamivudine—acquired immunodeficiency syndrome	0.000113	0.000559	CcSEcCtD
Acetaminophen—Fatigue—Saquinavir—acquired immunodeficiency syndrome	0.000113	0.000558	CcSEcCtD
Acetaminophen—Feeling abnormal—Ritonavir—acquired immunodeficiency syndrome	0.000112	0.000554	CcSEcCtD
Acetaminophen—Constipation—Saquinavir—acquired immunodeficiency syndrome	0.000112	0.000554	CcSEcCtD
Acetaminophen—Dyspnoea—Lamivudine—acquired immunodeficiency syndrome	0.000111	0.000551	CcSEcCtD
Acetaminophen—Diarrhoea—Indinavir—acquired immunodeficiency syndrome	0.000111	0.000551	CcSEcCtD
Acetaminophen—Vomiting—Zidovudine—acquired immunodeficiency syndrome	0.000111	0.00055	CcSEcCtD
Acetaminophen—Gastrointestinal pain—Ritonavir—acquired immunodeficiency syndrome	0.000111	0.00055	CcSEcCtD
Acetaminophen—Somnolence—Lamivudine—acquired immunodeficiency syndrome	0.000111	0.000549	CcSEcCtD
Acetaminophen—Rash—Zidovudine—acquired immunodeficiency syndrome	0.00011	0.000546	CcSEcCtD
Acetaminophen—Asthenia—Efavirenz—acquired immunodeficiency syndrome	0.00011	0.000546	CcSEcCtD
Acetaminophen—Dermatitis—Zidovudine—acquired immunodeficiency syndrome	0.00011	0.000545	CcSEcCtD
Acetaminophen—Dyspepsia—Lamivudine—acquired immunodeficiency syndrome	0.00011	0.000544	CcSEcCtD
Acetaminophen—Headache—Zidovudine—acquired immunodeficiency syndrome	0.00011	0.000542	CcSEcCtD
Acetaminophen—Pruritus—Efavirenz—acquired immunodeficiency syndrome	0.000109	0.000538	CcSEcCtD
Acetaminophen—Decreased appetite—Lamivudine—acquired immunodeficiency syndrome	0.000109	0.000537	CcSEcCtD
Acetaminophen—Hypersensitivity—Delavirdine—acquired immunodeficiency syndrome	0.000108	0.000536	CcSEcCtD
Acetaminophen—Urticaria—Ritonavir—acquired immunodeficiency syndrome	0.000108	0.000535	CcSEcCtD
Acetaminophen—Feeling abnormal—Saquinavir—acquired immunodeficiency syndrome	0.000108	0.000534	CcSEcCtD
Acetaminophen—Gastrointestinal disorder—Lamivudine—acquired immunodeficiency syndrome	0.000108	0.000533	CcSEcCtD
Acetaminophen—Fatigue—Lamivudine—acquired immunodeficiency syndrome	0.000108	0.000533	CcSEcCtD
Acetaminophen—Dizziness—Indinavir—acquired immunodeficiency syndrome	0.000108	0.000532	CcSEcCtD
Acetaminophen—Abdominal pain—Ritonavir—acquired immunodeficiency syndrome	0.000108	0.000532	CcSEcCtD
Acetaminophen—Body temperature increased—Ritonavir—acquired immunodeficiency syndrome	0.000108	0.000532	CcSEcCtD
Acetaminophen—Gastrointestinal pain—Saquinavir—acquired immunodeficiency syndrome	0.000107	0.00053	CcSEcCtD
Acetaminophen—Constipation—Lamivudine—acquired immunodeficiency syndrome	0.000107	0.000528	CcSEcCtD
Acetaminophen—Asthenia—Delavirdine—acquired immunodeficiency syndrome	0.000106	0.000522	CcSEcCtD
Acetaminophen—Diarrhoea—Efavirenz—acquired immunodeficiency syndrome	0.000105	0.00052	CcSEcCtD
Acetaminophen—Pruritus—Delavirdine—acquired immunodeficiency syndrome	0.000104	0.000515	CcSEcCtD
Acetaminophen—Urticaria—Saquinavir—acquired immunodeficiency syndrome	0.000104	0.000514	CcSEcCtD
Acetaminophen—Nausea—Zidovudine—acquired immunodeficiency syndrome	0.000104	0.000514	CcSEcCtD
Acetaminophen—Abdominal pain—Saquinavir—acquired immunodeficiency syndrome	0.000104	0.000512	CcSEcCtD
Acetaminophen—Body temperature increased—Saquinavir—acquired immunodeficiency syndrome	0.000104	0.000512	CcSEcCtD
Acetaminophen—Vomiting—Indinavir—acquired immunodeficiency syndrome	0.000104	0.000512	CcSEcCtD
Acetaminophen—Feeling abnormal—Lamivudine—acquired immunodeficiency syndrome	0.000103	0.000509	CcSEcCtD
Acetaminophen—Rash—Indinavir—acquired immunodeficiency syndrome	0.000103	0.000507	CcSEcCtD
Acetaminophen—Dermatitis—Indinavir—acquired immunodeficiency syndrome	0.000103	0.000507	CcSEcCtD
Acetaminophen—Gastrointestinal pain—Lamivudine—acquired immunodeficiency syndrome	0.000102	0.000505	CcSEcCtD
Acetaminophen—Headache—Indinavir—acquired immunodeficiency syndrome	0.000102	0.000504	CcSEcCtD
Acetaminophen—Dizziness—Efavirenz—acquired immunodeficiency syndrome	0.000102	0.000503	CcSEcCtD
Acetaminophen—Diarrhoea—Delavirdine—acquired immunodeficiency syndrome	0.000101	0.000498	CcSEcCtD
Acetaminophen—Hypersensitivity—Ritonavir—acquired immunodeficiency syndrome	0.0001	0.000496	CcSEcCtD
Acetaminophen—Urticaria—Lamivudine—acquired immunodeficiency syndrome	9.93e-05	0.000491	CcSEcCtD
Acetaminophen—Abdominal pain—Lamivudine—acquired immunodeficiency syndrome	9.88e-05	0.000488	CcSEcCtD
Acetaminophen—Body temperature increased—Lamivudine—acquired immunodeficiency syndrome	9.88e-05	0.000488	CcSEcCtD
Acetaminophen—Vomiting—Efavirenz—acquired immunodeficiency syndrome	9.78e-05	0.000484	CcSEcCtD
Acetaminophen—Asthenia—Ritonavir—acquired immunodeficiency syndrome	9.76e-05	0.000483	CcSEcCtD
Acetaminophen—Dizziness—Delavirdine—acquired immunodeficiency syndrome	9.73e-05	0.000481	CcSEcCtD
Acetaminophen—Rash—Efavirenz—acquired immunodeficiency syndrome	9.7e-05	0.000479	CcSEcCtD
Acetaminophen—Dermatitis—Efavirenz—acquired immunodeficiency syndrome	9.69e-05	0.000479	CcSEcCtD
Acetaminophen—Nausea—Indinavir—acquired immunodeficiency syndrome	9.67e-05	0.000478	CcSEcCtD
Acetaminophen—Hypersensitivity—Saquinavir—acquired immunodeficiency syndrome	9.65e-05	0.000477	CcSEcCtD
Acetaminophen—Headache—Efavirenz—acquired immunodeficiency syndrome	9.64e-05	0.000476	CcSEcCtD
Acetaminophen—Pruritus—Ritonavir—acquired immunodeficiency syndrome	9.63e-05	0.000476	CcSEcCtD
Acetaminophen—Asthenia—Saquinavir—acquired immunodeficiency syndrome	9.4e-05	0.000465	CcSEcCtD
Acetaminophen—Vomiting—Delavirdine—acquired immunodeficiency syndrome	9.36e-05	0.000463	CcSEcCtD
Acetaminophen—Diarrhoea—Ritonavir—acquired immunodeficiency syndrome	9.31e-05	0.00046	CcSEcCtD
Acetaminophen—Rash—Delavirdine—acquired immunodeficiency syndrome	9.28e-05	0.000459	CcSEcCtD
Acetaminophen—Dermatitis—Delavirdine—acquired immunodeficiency syndrome	9.27e-05	0.000458	CcSEcCtD
Acetaminophen—Pruritus—Saquinavir—acquired immunodeficiency syndrome	9.27e-05	0.000458	CcSEcCtD
Acetaminophen—Headache—Delavirdine—acquired immunodeficiency syndrome	9.22e-05	0.000456	CcSEcCtD
Acetaminophen—Hypersensitivity—Lamivudine—acquired immunodeficiency syndrome	9.21e-05	0.000455	CcSEcCtD
Acetaminophen—Nausea—Efavirenz—acquired immunodeficiency syndrome	9.14e-05	0.000452	CcSEcCtD
Acetaminophen—ABCB1—brain—acquired immunodeficiency syndrome	9.01e-05	0.00124	CbGeAlD
Acetaminophen—Dizziness—Ritonavir—acquired immunodeficiency syndrome	9e-05	0.000445	CcSEcCtD
Acetaminophen—Asthenia—Lamivudine—acquired immunodeficiency syndrome	8.97e-05	0.000443	CcSEcCtD
Acetaminophen—Diarrhoea—Saquinavir—acquired immunodeficiency syndrome	8.96e-05	0.000443	CcSEcCtD
Acetaminophen—Pruritus—Lamivudine—acquired immunodeficiency syndrome	8.84e-05	0.000437	CcSEcCtD
Acetaminophen—Nausea—Delavirdine—acquired immunodeficiency syndrome	8.74e-05	0.000432	CcSEcCtD
Acetaminophen—ABCB1—lymph node—acquired immunodeficiency syndrome	8.71e-05	0.0012	CbGeAlD
Acetaminophen—Dizziness—Saquinavir—acquired immunodeficiency syndrome	8.66e-05	0.000428	CcSEcCtD
Acetaminophen—Vomiting—Ritonavir—acquired immunodeficiency syndrome	8.65e-05	0.000428	CcSEcCtD
Acetaminophen—Rash—Ritonavir—acquired immunodeficiency syndrome	8.58e-05	0.000424	CcSEcCtD
Acetaminophen—Dermatitis—Ritonavir—acquired immunodeficiency syndrome	8.57e-05	0.000424	CcSEcCtD
Acetaminophen—Diarrhoea—Lamivudine—acquired immunodeficiency syndrome	8.55e-05	0.000423	CcSEcCtD
Acetaminophen—Headache—Ritonavir—acquired immunodeficiency syndrome	8.53e-05	0.000422	CcSEcCtD
Acetaminophen—Vomiting—Saquinavir—acquired immunodeficiency syndrome	8.33e-05	0.000412	CcSEcCtD
Acetaminophen—Dizziness—Lamivudine—acquired immunodeficiency syndrome	8.26e-05	0.000409	CcSEcCtD
Acetaminophen—Rash—Saquinavir—acquired immunodeficiency syndrome	8.26e-05	0.000408	CcSEcCtD
Acetaminophen—Dermatitis—Saquinavir—acquired immunodeficiency syndrome	8.25e-05	0.000408	CcSEcCtD
Acetaminophen—Headache—Saquinavir—acquired immunodeficiency syndrome	8.21e-05	0.000406	CcSEcCtD
Acetaminophen—Nausea—Ritonavir—acquired immunodeficiency syndrome	8.08e-05	0.0004	CcSEcCtD
Acetaminophen—Vomiting—Lamivudine—acquired immunodeficiency syndrome	7.94e-05	0.000393	CcSEcCtD
Acetaminophen—Rash—Lamivudine—acquired immunodeficiency syndrome	7.88e-05	0.00039	CcSEcCtD
Acetaminophen—Dermatitis—Lamivudine—acquired immunodeficiency syndrome	7.87e-05	0.000389	CcSEcCtD
Acetaminophen—Headache—Lamivudine—acquired immunodeficiency syndrome	7.83e-05	0.000387	CcSEcCtD
Acetaminophen—Nausea—Saquinavir—acquired immunodeficiency syndrome	7.78e-05	0.000385	CcSEcCtD
Acetaminophen—Nausea—Lamivudine—acquired immunodeficiency syndrome	7.42e-05	0.000367	CcSEcCtD
Acetaminophen—CNR1—GPCRs, Other—ACKR1—acquired immunodeficiency syndrome	1.45e-05	0.0498	CbGpPWpGaD
Acetaminophen—CNR1—Class A/1 (Rhodopsin-like receptors)—CCL3L1—acquired immunodeficiency syndrome	8.88e-06	0.0306	CbGpPWpGaD
Acetaminophen—CNR1—GPCR ligand binding—CCL3L1—acquired immunodeficiency syndrome	6.76e-06	0.0233	CbGpPWpGaD
Acetaminophen—CNR1—Class A/1 (Rhodopsin-like receptors)—ACKR1—acquired immunodeficiency syndrome	5.38e-06	0.0185	CbGpPWpGaD
Acetaminophen—CNR1—GPCRs, Other—CCR5—acquired immunodeficiency syndrome	5.2e-06	0.0179	CbGpPWpGaD
Acetaminophen—UGT1A6—Aryl Hydrocarbon Receptor Pathway—IFNG—acquired immunodeficiency syndrome	4.97e-06	0.0171	CbGpPWpGaD
Acetaminophen—CNR1—Class A/1 (Rhodopsin-like receptors)—CCL4—acquired immunodeficiency syndrome	4.87e-06	0.0168	CbGpPWpGaD
Acetaminophen—SULT2A1—Metabolism of lipids and lipoproteins—AGPS—acquired immunodeficiency syndrome	4.74e-06	0.0163	CbGpPWpGaD
Acetaminophen—UGT1A6—Aryl Hydrocarbon Receptor Pathway—IL2—acquired immunodeficiency syndrome	4.41e-06	0.0152	CbGpPWpGaD
Acetaminophen—CNR1—GPCR ligand binding—ACKR1—acquired immunodeficiency syndrome	4.1e-06	0.0141	CbGpPWpGaD
Acetaminophen—CNR1—G alpha (i) signalling events—CCR2—acquired immunodeficiency syndrome	3.78e-06	0.013	CbGpPWpGaD
Acetaminophen—CNR1—GPCR ligand binding—CCL4—acquired immunodeficiency syndrome	3.7e-06	0.0128	CbGpPWpGaD
Acetaminophen—CNR1—G alpha (i) signalling events—CXCR4—acquired immunodeficiency syndrome	3.55e-06	0.0122	CbGpPWpGaD
Acetaminophen—CNR1—G alpha (i) signalling events—CXCL12—acquired immunodeficiency syndrome	3.55e-06	0.0122	CbGpPWpGaD
Acetaminophen—CNR1—GPCRs, Class A Rhodopsin-like—CCR2—acquired immunodeficiency syndrome	3.51e-06	0.0121	CbGpPWpGaD
Acetaminophen—PTGS2—Calcium signaling in the CD4+ TCR pathway—CD40LG—acquired immunodeficiency syndrome	3.5e-06	0.0121	CbGpPWpGaD
Acetaminophen—CNR1—Signaling by GPCR—CCL3L1—acquired immunodeficiency syndrome	3.47e-06	0.012	CbGpPWpGaD
Acetaminophen—PTGS2—Calcium signaling in the CD4+ TCR pathway—CSF2—acquired immunodeficiency syndrome	3.47e-06	0.0119	CbGpPWpGaD
Acetaminophen—PTGS2—Calcium signaling in the CD4+ TCR pathway—IL4—acquired immunodeficiency syndrome	3.41e-06	0.0117	CbGpPWpGaD
Acetaminophen—SULT2A1—Corticotropin-releasing hormone—IL2—acquired immunodeficiency syndrome	3.39e-06	0.0117	CbGpPWpGaD
Acetaminophen—CNR1—Class A/1 (Rhodopsin-like receptors)—CCL3—acquired immunodeficiency syndrome	3.32e-06	0.0114	CbGpPWpGaD
Acetaminophen—CNR1—GPCRs, Class A Rhodopsin-like—CXCR4—acquired immunodeficiency syndrome	3.3e-06	0.0114	CbGpPWpGaD
Acetaminophen—SULT1E1—Metabolism—TAT—acquired immunodeficiency syndrome	3.27e-06	0.0113	CbGpPWpGaD
Acetaminophen—UGT1A6—Aryl Hydrocarbon Receptor Pathway—TNF—acquired immunodeficiency syndrome	3.21e-06	0.0111	CbGpPWpGaD
Acetaminophen—CNR1—Class A/1 (Rhodopsin-like receptors)—CCR2—acquired immunodeficiency syndrome	3.01e-06	0.0104	CbGpPWpGaD
Acetaminophen—SULT1A1—Metabolism—TAT—acquired immunodeficiency syndrome	2.88e-06	0.00993	CbGpPWpGaD
Acetaminophen—CNR1—Class A/1 (Rhodopsin-like receptors)—CXCR4—acquired immunodeficiency syndrome	2.83e-06	0.00973	CbGpPWpGaD
Acetaminophen—CNR1—Class A/1 (Rhodopsin-like receptors)—CXCL12—acquired immunodeficiency syndrome	2.83e-06	0.00973	CbGpPWpGaD
Acetaminophen—SULT1E1—Metabolism—AGPS—acquired immunodeficiency syndrome	2.78e-06	0.00959	CbGpPWpGaD
Acetaminophen—CNR1—G alpha (i) signalling events—CCL5—acquired immunodeficiency syndrome	2.7e-06	0.00931	CbGpPWpGaD
Acetaminophen—CNR1—GPCR ligand binding—CCL3—acquired immunodeficiency syndrome	2.53e-06	0.00872	CbGpPWpGaD
Acetaminophen—SULT2A1—Metabolism—TAT—acquired immunodeficiency syndrome	2.48e-06	0.00855	CbGpPWpGaD
Acetaminophen—SULT1A1—Metabolism—AGPS—acquired immunodeficiency syndrome	2.45e-06	0.00844	CbGpPWpGaD
Acetaminophen—CNR1—G alpha (i) signalling events—CCR5—acquired immunodeficiency syndrome	2.44e-06	0.00839	CbGpPWpGaD
Acetaminophen—NAT2—Metabolism—TAT—acquired immunodeficiency syndrome	2.37e-06	0.00815	CbGpPWpGaD
Acetaminophen—PTGS1—Overview of nanoparticle effects—TNF—acquired immunodeficiency syndrome	2.36e-06	0.00812	CbGpPWpGaD
Acetaminophen—CNR1—GPCR ligand binding—CCR2—acquired immunodeficiency syndrome	2.29e-06	0.00788	CbGpPWpGaD
Acetaminophen—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—CD40LG—acquired immunodeficiency syndrome	2.27e-06	0.00781	CbGpPWpGaD
Acetaminophen—CNR1—GPCRs, Class A Rhodopsin-like—CCR5—acquired immunodeficiency syndrome	2.26e-06	0.00779	CbGpPWpGaD
Acetaminophen—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—CSF2—acquired immunodeficiency syndrome	2.24e-06	0.00772	CbGpPWpGaD
Acetaminophen—UGT2B15—Metabolism—TAT—acquired immunodeficiency syndrome	2.23e-06	0.00767	CbGpPWpGaD
Acetaminophen—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—IL4—acquired immunodeficiency syndrome	2.21e-06	0.00759	CbGpPWpGaD
Acetaminophen—UGT1A1—Aryl Hydrocarbon Receptor Pathway—IFNG—acquired immunodeficiency syndrome	2.2e-06	0.00758	CbGpPWpGaD
Acetaminophen—UGT1A9—Aryl Hydrocarbon Receptor Pathway—IFNG—acquired immunodeficiency syndrome	2.2e-06	0.00758	CbGpPWpGaD
Acetaminophen—CNR1—GPCR ligand binding—CXCL12—acquired immunodeficiency syndrome	2.15e-06	0.00741	CbGpPWpGaD
Acetaminophen—CNR1—GPCR ligand binding—CXCR4—acquired immunodeficiency syndrome	2.15e-06	0.00741	CbGpPWpGaD
Acetaminophen—CNR1—Class A/1 (Rhodopsin-like receptors)—CCL5—acquired immunodeficiency syndrome	2.15e-06	0.0074	CbGpPWpGaD
Acetaminophen—SULT2A1—Metabolism—AGPS—acquired immunodeficiency syndrome	2.11e-06	0.00727	CbGpPWpGaD
Acetaminophen—CNR1—Signaling by GPCR—ACKR1—acquired immunodeficiency syndrome	2.1e-06	0.00724	CbGpPWpGaD
Acetaminophen—PTGS2—Calcium signaling in the CD4+ TCR pathway—IFNG—acquired immunodeficiency syndrome	2.06e-06	0.0071	CbGpPWpGaD
Acetaminophen—CNR1—Signaling Pathways—CCL3L1—acquired immunodeficiency syndrome	2.05e-06	0.00706	CbGpPWpGaD
Acetaminophen—NAT2—Metabolism—AGPS—acquired immunodeficiency syndrome	2.01e-06	0.00693	CbGpPWpGaD
Acetaminophen—UGT1A1—Aryl Hydrocarbon Receptor Pathway—IL2—acquired immunodeficiency syndrome	1.96e-06	0.00674	CbGpPWpGaD
Acetaminophen—UGT1A9—Aryl Hydrocarbon Receptor Pathway—IL2—acquired immunodeficiency syndrome	1.96e-06	0.00674	CbGpPWpGaD
Acetaminophen—CNR1—Class A/1 (Rhodopsin-like receptors)—CCR5—acquired immunodeficiency syndrome	1.94e-06	0.00667	CbGpPWpGaD
Acetaminophen—PTGS1—Overview of nanoparticle effects—IL6—acquired immunodeficiency syndrome	1.9e-06	0.00655	CbGpPWpGaD
Acetaminophen—CNR1—Signaling by GPCR—CCL4—acquired immunodeficiency syndrome	1.9e-06	0.00655	CbGpPWpGaD
Acetaminophen—UGT2B15—Metabolism—AGPS—acquired immunodeficiency syndrome	1.89e-06	0.00652	CbGpPWpGaD
Acetaminophen—PTGS2—Overview of nanoparticle effects—TNF—acquired immunodeficiency syndrome	1.87e-06	0.00644	CbGpPWpGaD
Acetaminophen—UGT1A6—Metabolism—TAT—acquired immunodeficiency syndrome	1.86e-06	0.0064	CbGpPWpGaD
Acetaminophen—PTGS2—Calcium signaling in the CD4+ TCR pathway—IL2—acquired immunodeficiency syndrome	1.83e-06	0.00631	CbGpPWpGaD
Acetaminophen—ABCB1—HIF-1-alpha transcription factor network—CXCR4—acquired immunodeficiency syndrome	1.7e-06	0.00585	CbGpPWpGaD
Acetaminophen—ABCB1—HIF-1-alpha transcription factor network—CXCL12—acquired immunodeficiency syndrome	1.7e-06	0.00585	CbGpPWpGaD
Acetaminophen—CNR1—GPCR ligand binding—CCL5—acquired immunodeficiency syndrome	1.64e-06	0.00564	CbGpPWpGaD
Acetaminophen—PTGS2—Spinal Cord Injury—CCR2—acquired immunodeficiency syndrome	1.6e-06	0.00551	CbGpPWpGaD
Acetaminophen—UGT1A6—Metabolism—AGPS—acquired immunodeficiency syndrome	1.58e-06	0.00544	CbGpPWpGaD
Acetaminophen—UGT1A9—Metabolism of lipids and lipoproteins—AGPS—acquired immunodeficiency syndrome	1.57e-06	0.00542	CbGpPWpGaD
Acetaminophen—PTGS2—Overview of nanoparticle effects—IL6—acquired immunodeficiency syndrome	1.51e-06	0.0052	CbGpPWpGaD
Acetaminophen—CNR1—GPCR ligand binding—CCR5—acquired immunodeficiency syndrome	1.47e-06	0.00508	CbGpPWpGaD
Acetaminophen—ABCB1—Allograft Rejection—CXCL12—acquired immunodeficiency syndrome	1.47e-06	0.00506	CbGpPWpGaD
Acetaminophen—UGT1A9—Aryl Hydrocarbon Receptor Pathway—TNF—acquired immunodeficiency syndrome	1.43e-06	0.00491	CbGpPWpGaD
Acetaminophen—UGT1A1—Aryl Hydrocarbon Receptor Pathway—TNF—acquired immunodeficiency syndrome	1.43e-06	0.00491	CbGpPWpGaD
Acetaminophen—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—IFNG—acquired immunodeficiency syndrome	1.33e-06	0.00459	CbGpPWpGaD
Acetaminophen—CNR1—Signaling by GPCR—CCL3—acquired immunodeficiency syndrome	1.3e-06	0.00447	CbGpPWpGaD
Acetaminophen—CNR1—GPCR downstream signaling—CCR2—acquired immunodeficiency syndrome	1.29e-06	0.00445	CbGpPWpGaD
Acetaminophen—PTGS1—Metabolism of lipids and lipoproteins—AGPS—acquired immunodeficiency syndrome	1.28e-06	0.00442	CbGpPWpGaD
Acetaminophen—CYP1A1—Aryl Hydrocarbon Receptor Pathway—IFNG—acquired immunodeficiency syndrome	1.26e-06	0.00436	CbGpPWpGaD
Acetaminophen—CNR1—Signaling Pathways—CCNT1—acquired immunodeficiency syndrome	1.24e-06	0.00428	CbGpPWpGaD
Acetaminophen—CNR1—Signaling Pathways—ACKR1—acquired immunodeficiency syndrome	1.24e-06	0.00428	CbGpPWpGaD
Acetaminophen—CNR1—GPCR downstream signaling—CXCL12—acquired immunodeficiency syndrome	1.22e-06	0.00419	CbGpPWpGaD
Acetaminophen—CNR1—GPCR downstream signaling—CXCR4—acquired immunodeficiency syndrome	1.22e-06	0.00419	CbGpPWpGaD
Acetaminophen—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—IL2—acquired immunodeficiency syndrome	1.18e-06	0.00408	CbGpPWpGaD
Acetaminophen—CNR1—Signaling by GPCR—CCR2—acquired immunodeficiency syndrome	1.17e-06	0.00405	CbGpPWpGaD
Acetaminophen—PTGS1—Selenium Micronutrient Network—ALB—acquired immunodeficiency syndrome	1.17e-06	0.00403	CbGpPWpGaD
Acetaminophen—CYP1A1—Aryl Hydrocarbon Receptor Pathway—IL2—acquired immunodeficiency syndrome	1.12e-06	0.00387	CbGpPWpGaD
Acetaminophen—CNR1—Signaling Pathways—CCL4—acquired immunodeficiency syndrome	1.12e-06	0.00387	CbGpPWpGaD
Acetaminophen—ABCB1—Allograft Rejection—CD40LG—acquired immunodeficiency syndrome	1.11e-06	0.00384	CbGpPWpGaD
Acetaminophen—ABCB1—Allograft Rejection—IL10—acquired immunodeficiency syndrome	1.11e-06	0.00384	CbGpPWpGaD
Acetaminophen—PTGS2—Spinal Cord Injury—IL4—acquired immunodeficiency syndrome	1.11e-06	0.00382	CbGpPWpGaD
Acetaminophen—CNR1—Signaling by GPCR—CXCR4—acquired immunodeficiency syndrome	1.1e-06	0.0038	CbGpPWpGaD
Acetaminophen—CNR1—Signaling by GPCR—CXCL12—acquired immunodeficiency syndrome	1.1e-06	0.0038	CbGpPWpGaD
Acetaminophen—ABCB1—Allograft Rejection—IL4—acquired immunodeficiency syndrome	1.08e-06	0.00373	CbGpPWpGaD
Acetaminophen—PTGS1—Selenium Micronutrient Network—IFNG—acquired immunodeficiency syndrome	1.07e-06	0.00368	CbGpPWpGaD
Acetaminophen—ABCB1—Allograft Rejection—HLA-B—acquired immunodeficiency syndrome	1.06e-06	0.00365	CbGpPWpGaD
Acetaminophen—TRPV1—Transmembrane transport of small molecules—ALB—acquired immunodeficiency syndrome	1.04e-06	0.00357	CbGpPWpGaD
Acetaminophen—PTGS2—Metabolism of lipids and lipoproteins—AGPS—acquired immunodeficiency syndrome	1.02e-06	0.00351	CbGpPWpGaD
Acetaminophen—SULT2A1—Metabolism of lipids and lipoproteins—ALB—acquired immunodeficiency syndrome	9.72e-07	0.00335	CbGpPWpGaD
Acetaminophen—PTGS2—Selenium Micronutrient Network—ALB—acquired immunodeficiency syndrome	9.29e-07	0.0032	CbGpPWpGaD
Acetaminophen—CNR1—GPCR downstream signaling—CCL5—acquired immunodeficiency syndrome	9.25e-07	0.00319	CbGpPWpGaD
Acetaminophen—PTGS2—Aryl Hydrocarbon Receptor—TNF—acquired immunodeficiency syndrome	9.22e-07	0.00318	CbGpPWpGaD
Acetaminophen—CNR1—GPCR downstream signaling—CSF2—acquired immunodeficiency syndrome	9.11e-07	0.00314	CbGpPWpGaD
Acetaminophen—CYP1A1—Metabolism of lipids and lipoproteins—AGPS—acquired immunodeficiency syndrome	9.03e-07	0.00311	CbGpPWpGaD
Acetaminophen—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—TNF—acquired immunodeficiency syndrome	8.63e-07	0.00297	CbGpPWpGaD
Acetaminophen—PTGS2—C-MYB transcription factor network—CD4—acquired immunodeficiency syndrome	8.5e-07	0.00293	CbGpPWpGaD
Acetaminophen—PTGS2—Selenium Micronutrient Network—IFNG—acquired immunodeficiency syndrome	8.48e-07	0.00292	CbGpPWpGaD
Acetaminophen—CNR1—Signaling by GPCR—CCL5—acquired immunodeficiency syndrome	8.4e-07	0.00289	CbGpPWpGaD
Acetaminophen—CNR1—GPCR downstream signaling—CCR5—acquired immunodeficiency syndrome	8.33e-07	0.00287	CbGpPWpGaD
Acetaminophen—CYP2C8—Metabolism of lipids and lipoproteins—AGPS—acquired immunodeficiency syndrome	8.28e-07	0.00285	CbGpPWpGaD
Acetaminophen—CNR1—Signaling by GPCR—CSF2—acquired immunodeficiency syndrome	8.28e-07	0.00285	CbGpPWpGaD
Acetaminophen—UGT1A1—Metabolism—TAT—acquired immunodeficiency syndrome	8.24e-07	0.00284	CbGpPWpGaD
Acetaminophen—UGT1A9—Metabolism—TAT—acquired immunodeficiency syndrome	8.24e-07	0.00284	CbGpPWpGaD
Acetaminophen—CYP1A1—Aryl Hydrocarbon Receptor—TNF—acquired immunodeficiency syndrome	8.18e-07	0.00282	CbGpPWpGaD
Acetaminophen—CYP1A1—Aryl Hydrocarbon Receptor Pathway—TNF—acquired immunodeficiency syndrome	8.18e-07	0.00282	CbGpPWpGaD
Acetaminophen—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IFNG—acquired immunodeficiency syndrome	8.06e-07	0.00278	CbGpPWpGaD
Acetaminophen—CNR1—Signaling Pathways—CCL3—acquired immunodeficiency syndrome	7.67e-07	0.00264	CbGpPWpGaD
Acetaminophen—CNR1—Signaling by GPCR—CCR5—acquired immunodeficiency syndrome	7.57e-07	0.00261	CbGpPWpGaD
Acetaminophen—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL2—acquired immunodeficiency syndrome	7.17e-07	0.00247	CbGpPWpGaD
Acetaminophen—UGT1A1—Metabolism—AGPS—acquired immunodeficiency syndrome	7.01e-07	0.00241	CbGpPWpGaD
Acetaminophen—UGT1A9—Metabolism—AGPS—acquired immunodeficiency syndrome	7.01e-07	0.00241	CbGpPWpGaD
Acetaminophen—CNR1—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	6.94e-07	0.00239	CbGpPWpGaD
Acetaminophen—PTGS1—Selenium Micronutrient Network—TNF—acquired immunodeficiency syndrome	6.91e-07	0.00238	CbGpPWpGaD
Acetaminophen—CYP2C9—Metabolism of lipids and lipoproteins—AGPS—acquired immunodeficiency syndrome	6.74e-07	0.00232	CbGpPWpGaD
Acetaminophen—PTGS1—Metabolism—TAT—acquired immunodeficiency syndrome	6.72e-07	0.00231	CbGpPWpGaD
Acetaminophen—PTGS2—Spinal Cord Injury—IFNG—acquired immunodeficiency syndrome	6.71e-07	0.00231	CbGpPWpGaD
Acetaminophen—ABCB1—Allograft Rejection—IFNG—acquired immunodeficiency syndrome	6.55e-07	0.00226	CbGpPWpGaD
Acetaminophen—CNR1—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	6.52e-07	0.00225	CbGpPWpGaD
Acetaminophen—CNR1—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	6.52e-07	0.00225	CbGpPWpGaD
Acetaminophen—CYP2A6—Metabolism—TAT—acquired immunodeficiency syndrome	6.35e-07	0.00219	CbGpPWpGaD
Acetaminophen—SLC22A6—SLC-mediated transmembrane transport—ALB—acquired immunodeficiency syndrome	6.08e-07	0.00209	CbGpPWpGaD
Acetaminophen—PTGS2—Spinal Cord Injury—IL2—acquired immunodeficiency syndrome	5.96e-07	0.00205	CbGpPWpGaD
Acetaminophen—ABCB1—Allograft Rejection—IL2—acquired immunodeficiency syndrome	5.82e-07	0.00201	CbGpPWpGaD
Acetaminophen—CYP1A2—Metabolism of lipids and lipoproteins—AGPS—acquired immunodeficiency syndrome	5.76e-07	0.00198	CbGpPWpGaD
Acetaminophen—SULT1E1—Metabolism—ALB—acquired immunodeficiency syndrome	5.71e-07	0.00197	CbGpPWpGaD
Acetaminophen—PTGS1—Metabolism—AGPS—acquired immunodeficiency syndrome	5.71e-07	0.00197	CbGpPWpGaD
Acetaminophen—PTGS1—Selenium Micronutrient Network—IL6—acquired immunodeficiency syndrome	5.58e-07	0.00192	CbGpPWpGaD
Acetaminophen—PTGS2—Selenium Micronutrient Network—TNF—acquired immunodeficiency syndrome	5.49e-07	0.00189	CbGpPWpGaD
Acetaminophen—CYP2A6—Metabolism—AGPS—acquired immunodeficiency syndrome	5.4e-07	0.00186	CbGpPWpGaD
Acetaminophen—PTGS2—Metabolism—TAT—acquired immunodeficiency syndrome	5.33e-07	0.00184	CbGpPWpGaD
Acetaminophen—CYP1A2—Aryl Hydrocarbon Receptor—TNF—acquired immunodeficiency syndrome	5.22e-07	0.0018	CbGpPWpGaD
Acetaminophen—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—acquired immunodeficiency syndrome	5.22e-07	0.0018	CbGpPWpGaD
Acetaminophen—PTGS2—Disease—APOBEC3G—acquired immunodeficiency syndrome	5.09e-07	0.00175	CbGpPWpGaD
Acetaminophen—SULT1A1—Metabolism—ALB—acquired immunodeficiency syndrome	5.03e-07	0.00173	CbGpPWpGaD
Acetaminophen—CYP2E1—Metabolism—TAT—acquired immunodeficiency syndrome	5.02e-07	0.00173	CbGpPWpGaD
Acetaminophen—CNR1—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	4.96e-07	0.00171	CbGpPWpGaD
Acetaminophen—CNR1—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	4.89e-07	0.00168	CbGpPWpGaD
Acetaminophen—CNR1—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	4.82e-07	0.00166	CbGpPWpGaD
Acetaminophen—CYP1A1—Metabolism—TAT—acquired immunodeficiency syndrome	4.73e-07	0.00163	CbGpPWpGaD
Acetaminophen—PTGS2—Metabolism—AGPS—acquired immunodeficiency syndrome	4.53e-07	0.00156	CbGpPWpGaD
Acetaminophen—CNR1—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	4.47e-07	0.00154	CbGpPWpGaD
Acetaminophen—PTGS2—Selenium Micronutrient Network—IL6—acquired immunodeficiency syndrome	4.43e-07	0.00153	CbGpPWpGaD
Acetaminophen—CNR1—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	4.37e-07	0.00151	CbGpPWpGaD
Acetaminophen—PTGS2—Spinal Cord Injury—TNF—acquired immunodeficiency syndrome	4.34e-07	0.00149	CbGpPWpGaD
Acetaminophen—CYP2C8—Metabolism—TAT—acquired immunodeficiency syndrome	4.34e-07	0.00149	CbGpPWpGaD
Acetaminophen—SULT2A1—Metabolism—ALB—acquired immunodeficiency syndrome	4.33e-07	0.00149	CbGpPWpGaD
Acetaminophen—PTGS2—Disease—CCNT1—acquired immunodeficiency syndrome	4.33e-07	0.00149	CbGpPWpGaD
Acetaminophen—CYP2E1—Metabolism—AGPS—acquired immunodeficiency syndrome	4.27e-07	0.00147	CbGpPWpGaD
Acetaminophen—ABCB1—Allograft Rejection—TNF—acquired immunodeficiency syndrome	4.24e-07	0.00146	CbGpPWpGaD
Acetaminophen—NAT2—Metabolism—ALB—acquired immunodeficiency syndrome	4.13e-07	0.00142	CbGpPWpGaD
Acetaminophen—CYP1A1—Metabolism—AGPS—acquired immunodeficiency syndrome	4.02e-07	0.00139	CbGpPWpGaD
Acetaminophen—UGT2B15—Metabolism—ALB—acquired immunodeficiency syndrome	3.88e-07	0.00134	CbGpPWpGaD
Acetaminophen—ABCB1—Metabolism—TAT—acquired immunodeficiency syndrome	3.78e-07	0.0013	CbGpPWpGaD
Acetaminophen—CYP2C8—Metabolism—AGPS—acquired immunodeficiency syndrome	3.69e-07	0.00127	CbGpPWpGaD
Acetaminophen—CYP2D6—Metabolism—TAT—acquired immunodeficiency syndrome	3.56e-07	0.00123	CbGpPWpGaD
Acetaminophen—CYP2C9—Metabolism—TAT—acquired immunodeficiency syndrome	3.53e-07	0.00122	CbGpPWpGaD
Acetaminophen—PTGS2—Spinal Cord Injury—IL6—acquired immunodeficiency syndrome	3.5e-07	0.00121	CbGpPWpGaD
Acetaminophen—UGT1A6—Metabolism—ALB—acquired immunodeficiency syndrome	3.24e-07	0.00112	CbGpPWpGaD
Acetaminophen—UGT1A9—Metabolism of lipids and lipoproteins—ALB—acquired immunodeficiency syndrome	3.23e-07	0.00111	CbGpPWpGaD
Acetaminophen—ABCB1—Metabolism—AGPS—acquired immunodeficiency syndrome	3.21e-07	0.00111	CbGpPWpGaD
Acetaminophen—SLC22A6—Transmembrane transport of small molecules—ALB—acquired immunodeficiency syndrome	3.09e-07	0.00106	CbGpPWpGaD
Acetaminophen—CYP2D6—Metabolism—AGPS—acquired immunodeficiency syndrome	3.03e-07	0.00104	CbGpPWpGaD
Acetaminophen—CYP1A2—Metabolism—TAT—acquired immunodeficiency syndrome	3.02e-07	0.00104	CbGpPWpGaD
Acetaminophen—CYP2C9—Metabolism—AGPS—acquired immunodeficiency syndrome	3e-07	0.00103	CbGpPWpGaD
Acetaminophen—PTGS2—Integrated Pancreatic Cancer Pathway—TNF—acquired immunodeficiency syndrome	2.95e-07	0.00102	CbGpPWpGaD
Acetaminophen—PTGS1—Metabolism of lipids and lipoproteins—ALB—acquired immunodeficiency syndrome	2.63e-07	0.000906	CbGpPWpGaD
Acetaminophen—CNR1—Signaling Pathways—IL2—acquired immunodeficiency syndrome	2.58e-07	0.00089	CbGpPWpGaD
Acetaminophen—CNR1—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	2.57e-07	0.000885	CbGpPWpGaD
Acetaminophen—CYP1A2—Metabolism—AGPS—acquired immunodeficiency syndrome	2.57e-07	0.000883	CbGpPWpGaD
Acetaminophen—CYP3A4—Metabolism—TAT—acquired immunodeficiency syndrome	2.33e-07	0.000802	CbGpPWpGaD
Acetaminophen—PTGS2—Disease—CXCR4—acquired immunodeficiency syndrome	2.27e-07	0.000783	CbGpPWpGaD
Acetaminophen—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—acquired immunodeficiency syndrome	2.09e-07	0.000721	CbGpPWpGaD
Acetaminophen—PTGS2—Metabolism of lipids and lipoproteins—ALB—acquired immunodeficiency syndrome	2.09e-07	0.000719	CbGpPWpGaD
Acetaminophen—CYP3A4—Metabolism—AGPS—acquired immunodeficiency syndrome	1.98e-07	0.000682	CbGpPWpGaD
Acetaminophen—CYP1A1—Metabolism of lipids and lipoproteins—ALB—acquired immunodeficiency syndrome	1.85e-07	0.000638	CbGpPWpGaD
Acetaminophen—CYP2C8—Metabolism of lipids and lipoproteins—ALB—acquired immunodeficiency syndrome	1.7e-07	0.000585	CbGpPWpGaD
Acetaminophen—PTGS2—Disease—CCR5—acquired immunodeficiency syndrome	1.56e-07	0.000537	CbGpPWpGaD
Acetaminophen—CNR1—Signaling Pathways—IL6—acquired immunodeficiency syndrome	1.52e-07	0.000523	CbGpPWpGaD
Acetaminophen—UGT1A1—Metabolism—ALB—acquired immunodeficiency syndrome	1.44e-07	0.000495	CbGpPWpGaD
Acetaminophen—UGT1A9—Metabolism—ALB—acquired immunodeficiency syndrome	1.44e-07	0.000495	CbGpPWpGaD
Acetaminophen—ABCB1—Transmembrane transport of small molecules—ALB—acquired immunodeficiency syndrome	1.41e-07	0.000485	CbGpPWpGaD
Acetaminophen—CYP2C9—Metabolism of lipids and lipoproteins—ALB—acquired immunodeficiency syndrome	1.38e-07	0.000476	CbGpPWpGaD
Acetaminophen—CYP1A2—Metabolism of lipids and lipoproteins—ALB—acquired immunodeficiency syndrome	1.18e-07	0.000407	CbGpPWpGaD
Acetaminophen—PTGS1—Metabolism—ALB—acquired immunodeficiency syndrome	1.17e-07	0.000403	CbGpPWpGaD
Acetaminophen—CYP2A6—Metabolism—ALB—acquired immunodeficiency syndrome	1.11e-07	0.000381	CbGpPWpGaD
Acetaminophen—PTGS2—Disease—CD4—acquired immunodeficiency syndrome	9.78e-08	0.000337	CbGpPWpGaD
Acetaminophen—PTGS2—Metabolism—ALB—acquired immunodeficiency syndrome	9.3e-08	0.00032	CbGpPWpGaD
Acetaminophen—CYP2E1—Metabolism—ALB—acquired immunodeficiency syndrome	8.75e-08	0.000301	CbGpPWpGaD
Acetaminophen—CYP1A1—Metabolism—ALB—acquired immunodeficiency syndrome	8.25e-08	0.000284	CbGpPWpGaD
Acetaminophen—CYP2C8—Metabolism—ALB—acquired immunodeficiency syndrome	7.56e-08	0.000261	CbGpPWpGaD
Acetaminophen—ABCB1—Metabolism—ALB—acquired immunodeficiency syndrome	6.59e-08	0.000227	CbGpPWpGaD
Acetaminophen—CYP2D6—Metabolism—ALB—acquired immunodeficiency syndrome	6.21e-08	0.000214	CbGpPWpGaD
Acetaminophen—CYP2C9—Metabolism—ALB—acquired immunodeficiency syndrome	6.16e-08	0.000212	CbGpPWpGaD
Acetaminophen—PTGS2—Disease—IL6—acquired immunodeficiency syndrome	5.29e-08	0.000182	CbGpPWpGaD
Acetaminophen—CYP1A2—Metabolism—ALB—acquired immunodeficiency syndrome	5.26e-08	0.000181	CbGpPWpGaD
Acetaminophen—CYP3A4—Metabolism—ALB—acquired immunodeficiency syndrome	4.06e-08	0.00014	CbGpPWpGaD
